Drug Shortage Report for TENORMIN
| Report ID | 192723 |
| Drug Identification Number | 02039532 |
| Brand name | TENORMIN |
| Common or Proper name | Tenormin |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATENOLOL |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 tabs |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2023-05-05 |
| Actual start date | 2023-05-05 |
| Estimated end date | |
| Actual end date | 2023-07-31 |
| Shortage status | Resolved |
| Updated date | 2023-08-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-08-01 | English | Compare |
| v2 | 2023-05-18 | French | Compare |
| v1 | 2023-05-18 | English | Compare |
Showing 1 to 3 of 3